| Infections of the Nervous System IA Lecture Outline© Hanuš Rozsypal |
| Meningism | Lumbar puncture | CSF examination | Bacterial meningitis |


|
Test
|
Item
|
Pattern | ||
| Normal | Purulent | Aseptic | ||
| Appearance |
|
pellucid | turbid | pellucid or haze |
| Cytology | Cell count (/3ml) | <10/3 | 1000-100000/3 | 10-1000/3 |
| Predominant cells | lymphocytes | polymorphonuclears | lymphocytes | |
| Chemistry | Protein | 0,1-0,4 g/l | 3-4 g/l and more | 0,4-1,0 g/l |
| Glucose | normal | low | normal | |
| Lactate | normal | high | normal | |
| Chloride | normal | normal | normal | |
| Microbiology | Gram stain | negative | positive (often) | negative |
| Latex agglutination | negative | positive (usually) | negative | |
| Bacterial culture | negative | positive (often) | negative | |
Major causative organisms (90%)
routes of infection
| Purulent Meningitis (Normal CT Scan) |
Cerebral Abscess * |
| Epidural Empyema * | Subdural Effusion ** |
![]() |
|
| Obstructive Hydrocephalus | Pneumocephalus |
| Age group | Common pathogens | Suggested regimens | Comments |
| Newborn | G- enteric bacilli, streptococci gr. B, D, Listeria monocytogenes | cefotaxime + ampicillin | |
| Infant 1-3 months | H. influenzae, S. pneumoniae, N. meningitidis, G- enteric bacilli, streptococci gr. B,D, L. monocytogenes | ceftriaxone/ cefotaxime + ampicillin | USA: + vancomycin *) |
| Infant 3 months to child to 7 years | H. influenzae, S. pneumoniae, N. meningitidis | ceftriaxone/ cefotaxime | USA: (+ vancomycin) |
| Ages 7-50 years | N. meningitidis, S. pneumoniae, L. monocytogenes | ceftriaxone/ cefotaxime or chloramphenicol | aqueous penicillin if dg. meningococcal meningitis is most-likely USA: (+ vancomycin) |
| Adult more than 50 years | S. pneumoniae, G- enteric bacilli, P. aeruginosa, L. monocytogenes | ceftriaxone/ cefotaxime (+ampicillin) | USA: (+ vancomycin) |
| Predisposing factor | Common pathogens | Suggested regimens | Comments |
| Alcoholism or other debilitating disease | S. pneumoniae, G- enteric bacilli, P. aeruginosa, L. monocytogenes | ceftriaxone/ cefotaxime (+ ampicillin) | USA: (+ vancomycin) |
| Head trauma, post-neurosurgery | S. pneumoniae, S. aureus, G- enteric bacilli, P. aeruginosa | chloramphenicol | USA: vancomycin + ceftazidim |
| Ventriculo-peritoneal or ventriculo-atrial shunt | S. epidermidis, S. aureus, G- enteric bacilli, Propionibacterium acnes | vancomycin + rifampicin or 3rd-gen. cephalosporin | |
| Chronic meningitis | M. tuberculosis, C. neoformans, neoplasm | No urgent empiric therapy | |
| HIV positive | C. neoformans, M. tuberculosis, T. pallidum, L. monocytogenes, S. pneumoniae, H. influenzae | ceftriaxone/ cefotaxime + ampicillin (+amphotericin B) |